• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者的氨甲酰化血红蛋白和氨甲酰化血浆蛋白

Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients.

作者信息

Balion C M, Draisey T F, Thibert R J

机构信息

Department of Chemistry and Biochemistry, University of Windsor, Ontario, Canada.

出版信息

Kidney Int. 1998 Feb;53(2):488-95. doi: 10.1046/j.1523-1755.1998.00777.x.

DOI:10.1046/j.1523-1755.1998.00777.x
PMID:9461111
Abstract

The carbamylation reaction in vivo involves the nonenzymatic, covalent attachment of isocyanic acid, the spontaneous dissociation product of urea, to proteins. Carbamylated proteins have been proposed as markers of uremia and indicators of uremic control. However, the utility of measuring carbamylated proteins has not been investigated adequately. Therefore, this study was done to determine the relationship between the carbamylation of long-lived protein (hemoglobin) with that of short-lived proteins (plasma proteins) in hemodialyzed patients. Significantly higher carbamylated hemoglobin (CHb; 157 +/- 40 microg valine hydantoin/g Hb) and carbamylated protein (CTP; 0.117 +/- 0.011 absorbance/mg protein) concentrations were found in hemodialyzed patients (N = 13) as compared to normal individuals (N = 9, 53 +/- 20 microg valine hydantoin/g Hb and 0.08 +/- 0.01 absorbance/mg protein, respectively). A high correlation was found between CHb and CTP concentrations (r = 0.87, P < 0.0001), demonstrating a strong relationship between these two different half-lived proteins. A six-month longitudinal study of seven hemodialyzed patients showed that the between subject correlations were significant for CHb versus CTP as well as CHb versus pre-dialysis urea. Correlations were not significant for CTP versus pre-dialysis urea or Kt/V, nor CHb versus Kt/V. Carbamylated hemoglobin fluctuated the most over this time period (30.1% +/- 20.2%), pre-dialysis urea and CTP varied less (18.3% +/- 13.4% and 14.9% +/- 7.5%, respectively), and Kt/V varied the least (6.3% +/- 3.3%). Within subject correlations were not significant between any two tests. It is unclear whether the lack of correlations found is real or a function of the small sample size. However, these data do show that CHb and CTP are positively associated and reflect the degree of urea exposure in the blood, but their usefulness for patients on maintenance hemodialysis is not clear.

摘要

体内的氨甲酰化反应涉及尿素的自发解离产物异氰酸与蛋白质的非酶促共价结合。氨甲酰化蛋白质已被提议作为尿毒症的标志物和尿毒症控制的指标。然而,测量氨甲酰化蛋白质的实用性尚未得到充分研究。因此,本研究旨在确定血液透析患者中长寿蛋白质(血红蛋白)的氨甲酰化与短寿蛋白质(血浆蛋白质)的氨甲酰化之间的关系。与正常个体(N = 9,分别为53±20微克乙内酰脲缬氨酸/克血红蛋白和0.08±0.01吸光度/毫克蛋白质)相比,血液透析患者(N = 13)中氨甲酰化血红蛋白(CHb;157±40微克乙内酰脲缬氨酸/克血红蛋白)和氨甲酰化蛋白质(CTP;0.117±0.011吸光度/毫克蛋白质)的浓度显著更高。发现CHb和CTP浓度之间存在高度相关性(r = 0.87,P < 0.0001),表明这两种不同半衰期的蛋白质之间存在密切关系。对7名血液透析患者进行的为期6个月的纵向研究表明,CHb与CTP以及CHb与透析前尿素之间的受试者间相关性显著。CTP与透析前尿素或Kt/V之间以及CHb与Kt/V之间的相关性不显著。在此期间,氨甲酰化血红蛋白波动最大(30.1%±20.2%),透析前尿素和CTP变化较小(分别为18.3%±13.4%和14.9%±7.5%),而Kt/V变化最小(6.3%±3.3%)。任何两项测试之间的受试者内相关性均不显著。尚不清楚所发现的缺乏相关性是真实的还是样本量小的结果。然而,这些数据确实表明CHb和CTP呈正相关,并反映了血液中尿素暴露的程度,但它们对维持性血液透析患者的实用性尚不清楚。

相似文献

1
Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients.血液透析患者的氨甲酰化血红蛋白和氨甲酰化血浆蛋白
Kidney Int. 1998 Feb;53(2):488-95. doi: 10.1046/j.1523-1755.1998.00777.x.
2
Carbamylated hemoglobin: a potential marker for the adequacy of hemodialysis therapy in end-stage renal failure.
Kidney Int. 1996 Oct;50(4):1344-51. doi: 10.1038/ki.1996.447.
3
Temporal changes and reversibility of carbamylated hemoglobin in renal failure.肾衰竭中氨甲酰化血红蛋白的时间变化及可逆性
Am J Kidney Dis. 1997 Jul;30(1):36-40. doi: 10.1016/s0272-6386(97)90562-x.
4
Carbamylated hemoglobin in hemodialysis patients.血液透析患者中的氨甲酰化血红蛋白
Am J Kidney Dis. 1997 Sep;30(3):361-5. doi: 10.1016/s0272-6386(97)90280-8.
5
Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis.血液透析开始后蛋白质氨甲酰化的纵向变化及死亡风险
Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1809-1816. doi: 10.2215/CJN.02390316. Epub 2016 Jul 21.
6
Determination of carbamylated hemoglobin by high-performance liquid chromatography.采用高效液相色谱法测定氨甲酰化血红蛋白。
Clin Chem. 1990 Apr;36(4):607-10.
7
Carbamylated hemoglobin as a therapeutic marker in hemodialysis.氨基甲酰化血红蛋白作为血液透析中的治疗标志物。
Nephron. 2002 Jun;91(2):228-34. doi: 10.1159/000058397.
8
Homocitrulline as marker of protein carbamylation in hemodialyzed patients.血液透析患者蛋白质氨甲酰化的标志物:瓜氨酸。
Clin Chim Acta. 2016 Sep 1;460:5-10. doi: 10.1016/j.cca.2016.06.009. Epub 2016 Jun 11.
9
Factors determining hemoglobin carbamylation in renal failure.肾衰竭中决定血红蛋白氨甲酰化的因素。
Kidney Int. 1995 Nov;48(5):1605-10. doi: 10.1038/ki.1995.454.
10
Carbamylated haemoglobin in chronic renal failure.慢性肾衰竭中的氨甲酰化血红蛋白
Clin Chim Acta. 1988 Dec 30;178(3):297-303. doi: 10.1016/0009-8981(88)90238-0.

引用本文的文献

1
Avenues for post-translational protein modification prevention and therapy.翻译:用于预防和治疗翻译后蛋白质修饰的途径。
Mol Aspects Med. 2022 Aug;86:101083. doi: 10.1016/j.mam.2022.101083. Epub 2022 Feb 25.
2
Localisation of citrullinated and carbamylated proteins in inflamed gingival tissues from rheumatoid arthritis patients.类风湿关节炎患者炎症性牙龈组织中瓜氨酸化和氨甲酰化蛋白的定位。
Clin Oral Investig. 2021 Mar;25(3):1441-1450. doi: 10.1007/s00784-020-03452-9. Epub 2020 Jul 12.
3
Detection and Characterization of a Biochemical Signature Associated with Diabetic Nephropathy Using Near-infrared Spectroscopy on Tissue Sections.
利用组织切片的近红外光谱检测与糖尿病肾病相关的生化特征并进行表征。
J Clin Med. 2019 Jul 12;8(7):1022. doi: 10.3390/jcm8071022.
4
Management of Diabetes Mellitus in Normal Renal Function, Renal Dysfunction and Renal Transplant Recipients, Focusing on Glucagon-Like Peptide-1 Agonist: A Review Based upon Current Evidence.正常肾功能、肾功能障碍和肾移植受者的糖尿病管理,重点关注胰高血糖素样肽-1 激动剂:基于现有证据的综述。
Int J Mol Sci. 2019 Jun 28;20(13):3152. doi: 10.3390/ijms20133152.
5
Mechanisms and consequences of carbamoylation.氨甲酰化的机制和后果。
Nat Rev Nephrol. 2017 Sep;13(9):580-593. doi: 10.1038/nrneph.2017.103. Epub 2017 Jul 31.
6
The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis.翻译后修饰在风湿性疾病中的作用:聚焦类风湿关节炎
J Immunol Res. 2015;2015:712490. doi: 10.1155/2015/712490. Epub 2015 May 18.
7
Protein carbamylation in kidney disease: pathogenesis and clinical implications.肾脏疾病中的蛋白质氨甲酰化:发病机制及临床意义
Am J Kidney Dis. 2014 Nov;64(5):793-803. doi: 10.1053/j.ajkd.2014.04.034. Epub 2014 Jul 16.
8
Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.血清白蛋白的氨甲酰化与终末期肾病的促红细胞生成素抵抗。
Clin J Am Soc Nephrol. 2013 Nov;8(11):1927-34. doi: 10.2215/CJN.04310413. Epub 2013 Aug 22.
9
Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.血清白蛋白的氨甲酰化作用作为肾衰竭患者死亡率的一个危险因素。
Sci Transl Med. 2013 Mar 6;5(175):175ra29. doi: 10.1126/scitranslmed.3005218.
10
Effects of amino acids and albumin on erythropoietin carbamoylation.氨基酸和白蛋白对促红细胞生成素氨甲酰化的影响。
Clin Exp Nephrol. 2013 Aug;17(4):575-81. doi: 10.1007/s10157-012-0751-y. Epub 2012 Dec 11.